Time to peak serum antibody response to influenza vaccine in the elderly

被引：38

作者：

Gross, PA

Russo, C

Teplitzky, M

Dran, S

Cataruozolo, P

Munk, G

机构：

[1] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,NEWARK,NJ

[2] CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT INTERNAL MED,NEW YORK,NY 10021

来源：

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY | 1996年 / 3卷 / 03期

关键词：

D O I：

10.1128/CDLI.3.3.361-362.1996

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The earliest time at which serum antibody peaks following administration of influenza virus vaccine in elderly persons is not clearly defined. We compared the time intervals of 2 and 4 weeks after vaccination. A commercial trivalent vaccine containing the hemagglutinins of influenza viruses A/Texas/36/91(H1N1), A/Shangdong/9/93(H3N2), and B/Panama/45/90 was used. The hemagglutination inhibition antibody titers at 2 weeks after vaccination were identical to the hemagglutination inhibition antibody titers at 4 weeks for all three vaccine components.

引用

页码：361 / 362

页数：2

共 8 条

[1] DEVELOPMENT AND PERSISTENCE OF LOCAL AND SYSTEMIC ANTIBODY-RESPONSES IN ADULTS GIVEN LIVE ATTENUATED OR INACTIVATED INFLUENZA-A VIRUS-VACCINE [J].

CLEMENTS, ML ;

MURPHY, BR .

JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 23 (01) :66-72

[2]

EVANS AS, 1973, SEROLOGICAL EPIDEMIO, P69

[3] A/HONG KONG INFLUENZA IMMUNITY 3 YEARS AFTER IMMUNIZATION [J].

FOY, HM ;

COONEY, MK ;

MCMAHAN, R .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 226 (07) :758-761

[4] CONTROLLED DOUBLE-BLIND COMPARISON OF REACTOGENICITY, IMMUNOGENICITY, AND PROTECTIVE EFFICACY OF WHOLE-VIRUS AND SPLIT-PRODUCT INFLUENZA VACCINES IN CHILDREN [J].

GROSS, PA ;

ENNIS, FA ;

GAERLAN, PF ;

DENSON, LJ ;

DENNING, CR ;

SCHIFFMAN, D .

JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (05) :623-632

[5]

GROSS PA, 1979, J CLIN MICROBIOL, V10, P381

[6]

Kilbourne ED, 1987, INFLUENZA, P291

[7] TIME TO PEAK SERUM ANTIBODY-RESPONSE TO INFLUENZA VACCINE [J].

RASTOGI, S ;

GROSS, PA ;

BONELLI, J ;

DRAN, S ;

LEVANDOWSKI, RA ;

RUSSO, C ;

WEKSLER, ME ;

KAYE, D ;

LEVISON, M ;

ABRUTYN, E ;

MURASKO, D ;

MOSSEY, J ;

DEICHMILLER, S ;

HILSEN, R .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (01) :120-121

[8]

1995, MMWR-MORBID MORTAL W, V44, P1

← 1 →